Abstract
Abstract Introduction New Kidney Disease Improving Global Outcomes guidelines represent a significant change from the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative, which indicate that the urinary albumin/ creatinine ratio is now integral to the classification of chronic kidney disease. The urinary albumin/creatinine ratio has been found to be fundamentally important for both the diagnosis and the prognosis of chronic kidney disease. It is now recommended that all patients with diabetes or hypertension be screened annually with this test. The presence of albuminuria helps decide the medications for the treatment of hypertension. This review discusses the importance of urine albumin–creatinine ratio in chronic kidney disease. Conclusion More research is needed to determine definitively whether or not the treatment of albuminuria delays the progression of chronic kidney disease and reduces mortality.
Highlights
Introduction New Kidney Disease Improving GlobalOutcomes guidelines represent a significant change from the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative, which indicate that the urinary albumin/ creatinine ratio is integral to the classification of chronic kidney disease
The 2012 Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines[1] represent a significant update from the 2002 National Kidney Foundations Kidney Disease Outcomes Quality Initiative (KDOQI)[2], which indicates that the urinary albumin–creatinine ratio
The urinary albumin–creatinine ratio (UACR) is found to be fundamentally important for both the diagnosis and the prognosis of chronic kidney disease (CKD)
Summary
Outcomes guidelines represent a significant change from the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative, which indicate that the urinary albumin/ creatinine ratio is integral to the classification of chronic kidney disease. The urinary albumin/creatinine ratio has been found to be fundamentally important for both the diagnosis and the prognosis of chronic kidney disease. This review discusses the importance of urine albumin–creatinine ratio in chronic kidney disease. The 2012 Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines[1] represent a significant update from the 2002 National Kidney Foundations Kidney Disease Outcomes Quality Initiative (KDOQI)[2], which indicates that the urinary albumin–creatinine ratio (UACR) is integral to the classification of chronic kidney disease (CKD).
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call